Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6569-6575

  Na, Shin Young ^a   Eujen, Heike ^a   Göbel, Kerstin ^a   Meuth, Sven G ^a   Martens, Kati ^a   Wiendl, Heinz ^a   Hünig, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFICACY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROPHYLAXIS; TARGET CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL;

EID: 71549141283     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804200     Document Type: Article

References (31)

1. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103: 4222-4231.
2. Jurewicz, A., W. E. Biddison, and J. P. Antel. 1998. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160: 3056-3059. (Pubitemid 28136763)
3. + cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172: 5120-5127.
4. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91: 10859-10863.
5. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
6. Junker, A., J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair. 2007. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130: 2789-2799. (Pubitemid 350033964)
7. + T cells in multiple sclerosis: a new target for therapy? Brain 128: 1747-1763.
8. + T cells in multiple sclerosis. Autoimmunity 23: 127-138.
9. + T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 101: 2428-2433.
10. Grenier, Y., T. C. Ruijs, Y. Robitaille, A. Olivier, and J. P. Antel. 1989. Immunohistochemical studies of adult human glial cells. J. Neuroimmunol. 21: 103-115. (Pubitemid 19031378)
11. + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35: 76-85.
12. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166: 7579-7587.
13. Mars, L. T., J. Bauer, D. A. Gross, F. Bucciarelli, H. Firat, D. Hudrisier, F. Lemonnier, K. Kosmatopoulos, and R. S. Liblau. 2007. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A* 0201-transgenic mice. J. Immunol. 179: 5090-5098.
14. Saxena, A., J. Bauer, T. Scheikl, J. Zappulla, M. Audebert, S. Desbois, A. Waisman, H. Lassmann, R. S. Liblau, and L. T. Mars. 2008. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181: 1617-1621.
15. + T-cells in a model for multiple sclerosis. J. Exp. Med. 194: 669-676.
16. Andersen, P. S., A. Stryhn, B. E. Hansen, L. Fugger, J. Engberg, and S. Buus. 1996. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci. USA 93: 1820-1824. (Pubitemid 26079838)
17. Duc, H. T., P. Rucay, S. Righenzi, O. Halle-Pannenko, and P. Kourilsky. 1993. Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens. Int. Immunol. 5: 427-431.
18. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726. (Pubitemid 27305734)
19. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4: 565-571. (Pubitemid 26233310)
20. Hogquist, K. A., M. A. Gavin, and M. J. Bevan. 1993. Positive selection of CD8 T-cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J. Exp. Med. 177: 1469-1473.
21. Alam, S. M., P. J. Travers, J. L. Wung, W. Naholds, S. Redpath, S. C. Jameson, and N. R. J. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature 381: 616-620.
22. Cao, Y., C. Toben, S. Y. Na, K. Stark, L. Nitschke, A. Peterson, R. Gold, A. Schimpl, and T. Hunig. 2006. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 36: 207-215. (Pubitemid 43116407)
23. Na, S. Y., Y. Cao, C. Toben, L. Nitschke, C. Stadelmann, R. Gold, A. Schimpl, and T. Hunig. 2008. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131: 2353-2365.
24. Cao, Y. A., A. J. Wagers, A. Beilhack, J. Dusich, M. H. Bachmann, R. S. Negrin, I. L. Weissman, and C. H. Contag. 2004. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA 101: 221-226.
25. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
26. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21: 2891-2894.
27. Malarkannan, S., M. Afkarian, and N. Shastri. 1995. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182: 1739-1750.
28. Dalakas, M. C., and R. Hohlfeld. 2003. Polymyositis and dermatomyositis. Lancet 362: 971-982.
29. Stuve, O., S. Cepok, B. Elias, A. Saleh, H. P. Hartung, B. Hemmer, and B. C. Kieseier. 2005. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch. Neurol. 62: 1620-1623. (Pubitemid 41434570)
30. Jacobs, L., J. O'Malley, A. Freeman, and R. Ekes. 1981. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science 214: 1026-1028. (Pubitemid 12220081)
31. + T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis. J. Immunol. 175: 8365-8378.